Hypogonadotropic Hypogonadism — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for hypogonadotropic hypogonadism. 97 active patents protecting 2 drugs from 2+ originators. First major cliff: 2026. Daily refresh.

2
Approved drugs
97
Active US patents
69/100
Avg vulnerability
—
Annual revenue covered

Originators in Hypogonadotropic Hypogonadism

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Marius 61 patents Besins Hlthcare 36 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating hypogonadotropic hypogonadism. Each bar = one year. Y-axis scaled to peak year (34 patents).

24
26
9
27
6
29
34
30
6
33
8
34
1
37
4
39
1
40
4
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aveed
TESTOSTERONE UNDECANOATE
 Marius 61 65 — 2027-01-06
Androgel
TESTOSTERONE
 Besins Hlthcare 36 72 — 2026-10-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11331325 Aveed method of use 88 2027-01-06
11331325 Aveed method of use 88 2027-01-06
11331325 Aveed method of use 88 2027-01-06
8741881 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8466137 Androgel method of use 85 2026-10-12
8466138 Androgel method of use 85 2026-10-12
8741881 Androgel method of use 85 2026-10-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10617696 Aveed composition of matter 10 2030-04-12
10617696 Aveed composition of matter 10 2030-04-12
10617696 Aveed composition of matter 10 2030-04-12
8778916 Aveed formulation 48 2030-04-12
8778916 Aveed formulation 48 2030-04-12
8778916 Aveed formulation 48 2030-04-12
11590146 Aveed formulation 56 2030-12-31
10576090 Aveed formulation 56 2030-12-31
11590146 Aveed formulation 56 2030-12-31
10576090 Aveed formulation 56 2030-12-31

Related